Received Apr 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (QUADRACEL) | SANOFI PASTEUR | 5 | — | IM / UN |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | IM / UN |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | — | IM / UN |
Beginning in April 2024, my daughter began reporting a recurring sensation described as a "leg fizzle" in her left leg. Over the following weeks, these sensations progressed into observable physical seizure activity, which began in May 2024. An EEG was performed in May, confirming seizure activity. Both MRI and CT scans were conducted and returned normal findings. Despite these normal imaging results, the seizure activity has continued to progress. She was officially diagnosed with a seizure disorder in mid-2024 and began treatment shortly thereafter. She is currently taking Aptiom (eslicarbazepine acetate) and lacosamide as prescribed anticonvulsant medications. However, she continues to experience nightly seizures, indicating that the condition is not fully controlled by current treatment.
No
none
Hiya Multivitamin
walnuts and cashews
EEG (24 hours ) May 2024 , CT and MRI with and without Contrast May of 2024, EEG in October of 2024